CAAS Capital Management’s Labcorp LH Stock Holding History

CAAS Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,275	Closed	-$1.59M	–	1169
2021 Q1	$1.59M	Buy	+7,275	New	+$1.46M	0.02%	657

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CAAS Capital Management's LH Position: Q2 2021 in Review

CAAS Capital Management sold out of Labcorp (LH) in Q2 2021, closing a stake of 7,275 shares — an estimated $1.59M sold.

CAAS Capital Management first reported a position in LH in Q1 2021 and held it in 1 quarter. The position peaked at $1.59M in Q1 2021. 948 funds tracked by Wall St. Rank hold LH as of Q2 2021.

CAAS Capital Management reported no remaining Labcorp position as of Q2 2021 after selling out during the quarter.
CAAS Capital Management sold 7,275 Labcorp shares in Q2 2021, an estimated $1.59M.
CAAS Capital Management first reported a position in Labcorp in Q1 2021 and held it in 1 quarter.
CAAS Capital Management's Labcorp position peaked at $1.59M in Q1 2021.
948 funds tracked by Wall St. Rank held Labcorp as of Q2 2021.

Based on CAAS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.